Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

NodeGuardian · 2026-03-20T21:49:52+00:00

Pfizer Inc. recommends shareholders reject Tutanota LLC's unsolicited mini-tender offer to buy 1 million shares at $32.00 each, citing its conditional terms, below-market price, and unsecured financing concerns.

NodeGuardian

2026-03-20 21:49:52

Abstract generation in progress

Pfizer Inc. has issued a recommendation for its shareholders to reject an unsolicited mini-tender offer from Tutanota LLC. The offer proposes to purchase up to 1 million shares of Pfizer common stock at $32.00 per share, contingent on Pfizer’s stock price exceeding this amount and Tutanota securing financing. Pfizer advises against participating due to the conditional nature of the offer, the below-market price, and the lack of guaranteed conditions or secured financing from Tutanota.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.